Related Experiment Video

Updated: May 22, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Eukaryotic expression vectors bearing genes encoding cytotoxic proteins for cancer gene therapy

Elena M Glinka1

  • 1Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia. em_glinka@mail.ru

Plasmid
|May 23, 2012
PubMed

Insights

Cancer gene therapy utilizes vectors to deliver toxic genes specifically to tumor cells, offering a promising treatment approach. Different vectors show varying efficiencies in killing cancer cells, highlighting the need for tailored therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Cancer gene therapy aims to selectively eliminate tumor cells.
  • Viral and non-viral delivery systems are employed, each with limitations.
  • Transcriptional targeting allows for cancer cell-specific expression of toxic genes.

Purpose of the Study:

  • To review vectors designed for cancer gene therapy.
  • To summarize data on vectors encoding cytotoxic proteins like diphtheria toxin and Pseudomonas exotoxin A.
  • To analyze the efficacy of different promoters in driving toxic gene expression in cancer cells.

Main Methods:

  • Review of existing literature on cancer gene therapy vectors.
  • Analysis of data on vectors utilizing tissue/tumor-specific and constitutive promoters.
  • Focus on vectors encoding diphtheria toxin, Pseudomonas exotoxin A, caspases, gef, streptolysin, and melittin.

Main Results:

  • Various vectors have been developed to kill cancer cells, with some successfully suppressing tumors.
  • Vectors exhibit differential efficiency in killing cancer cell lines, even within the same cancer type.
  • The choice of promoter and cytotoxic gene influences the efficacy of cancer cell growth inhibition.

Conclusions:

  • Cancer gene therapy holds significant promise for cancer treatment.
  • Vector design, including promoter selection and cytotoxic payload, is critical for therapeutic success.
  • Further research is needed to optimize vector efficiency and overcome cell-line-specific responses for improved cancer treatment outcomes.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.